Vinod Kateki, Panarelli Joseph F, Gentile Ronald C, Sidoti Paul A
Department of Ophthalmology, Icahn School of Medicine at Mount Sinai and New York Eye and Ear Infirmary of Mount Sinai, New York, NY.
J Glaucoma. 2017 Mar;26(3):266-271. doi: 10.1097/IJG.0000000000000611.
The purpose of the study was to report long-term outcomes and complications of Baerveldt glaucoma implant (BGI) surgery with pars plana tube insertion in children.
The medical records of consecutive aphakic and pseudophakic children (<16 y of age) who underwent BGI surgery with pars plana tube insertion between 1990 and 2013 were retrospectively reviewed. Main outcome measures were intraocular pressure and number of glaucoma medications. Postoperative complications were recorded. Failure was defined as an intraocular pressure <5 or ≥21 mm Hg (with or without glaucoma medications), loss of light perception, or need for additional glaucoma surgery.
Thirty-seven children were identified with a mean age of 6.0±4.7 years (range, 4 mo to 14.5 y). Mean follow-up after pars plana BGI surgery was 6.5±3.4 years (range, 9 mo to 12.8 y) for patients who met success criteria. Mean intraocular pressure and mean number of glaucoma medications at most recent follow-up for patients with successful intraocular pressure control were 13.8±4.1 and 2.3±1.9 mm Hg, respectively. The Kaplan-Meier survival analysis revealed 1-, 3-, 5-, and 7-year success rates of 94.5%, 74.6%, 65.0%, and 45.8%, respectively. Complications included tube exposure in 1 patient (2.7%), tube obstruction in 8 patients (21.6%), and retinal detachment in 9 patients (24.3%). Seventeen patients (45.9%) failed due to inadequate intraocular pressure control, of whom 9 (24.3%) required additional glaucoma surgery.
Although pars plana BGI surgery is a reasonable option for managing refractory glaucoma in aphakic and pseudophakic children, surgeons must be aware of the potential need for additional glaucoma surgery and/or posterior segment complications with extended follow-up.
本研究旨在报告儿童经平坦部植入Baerveldt青光眼引流物(BGI)手术的长期疗效和并发症。
回顾性分析1990年至2013年间连续接受经平坦部植入BGI手术的无晶状体和人工晶状体儿童(年龄<16岁)的病历。主要观察指标为眼压和青光眼药物使用数量。记录术后并发症。手术失败定义为眼压<5或≥21 mmHg(无论是否使用青光眼药物)、无光感或需要再次进行青光眼手术。
共纳入37例儿童,平均年龄6.0±4.7岁(范围4个月至14.5岁)。符合成功标准的患者经平坦部BGI手术后平均随访6.5±3.4年(范围9个月至12.8年)。眼压控制成功的患者在最近一次随访时的平均眼压和平均青光眼药物使用数量分别为13.8±4.1 mmHg和2.3±1.9种。Kaplan-Meier生存分析显示,1年、3年、5年和7年的成功率分别为94.5%、74.6%、65.0%和45.8%。并发症包括1例(2.7%)引流管暴露、8例(21.6%)引流管阻塞和9例(24.3%)视网膜脱离。17例(45.9%)患者因眼压控制不佳而手术失败,其中9例(24.3%)需要再次进行青光眼手术。
尽管经平坦部BGI手术是治疗无晶状体和人工晶状体儿童难治性青光眼的合理选择,但外科医生必须意识到长期随访中可能需要再次进行青光眼手术和/或发生后段并发症。